InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Morrison Scott W, Director. Director active across 3 companies, notably Global Blood Therapeutics, Inc.. Cumulatively, 15 filings have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €760k. Activity tracked since 9 September 2021. The latest transaction was disclosed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Morrison Scott W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
1,334 sharesCommon StockSEC:0001662426-25-000005:0
10,831 shares0American Depositary SharesSEC:0000905148-25-002218:0
3,350 sharesCommon StockSEC:0001819790-25-000090:0
23,799 shares@ US$30.046958.1% of flowAmerican Depositary SharesSEC:0000905148-25-001598:0
6,016 shares0Common StockSEC:0001819790-24-000115:0
1,333 sharesCommon StockSEC:0001819790-24-000113:0
3,350 sharesCommon StockSEC:0001819790-24-000099:0
21,253 shares0American Depositary SharesSEC:0000905148-24-001749:0
1,333 sharesCommon StockSEC:0001819790-23-000075:0
18,903 shares@ US$26.4541.9% of flowAmerican Depositary SharesSEC:0000950170-23-031116:0
6,637 sharesCommon StockSEC:0000899243-22-033163:0
3,600 sharesCommon StockSEC:0000899243-22-022888:0
7,345 shares0Ordinary SharesSEC:0000899243-21-040423:0
4,800 shares@ US$30.2089100.0% of flowCommon StockSEC:0000899243-21-035590:0
3,037 sharesCommon StockSEC:0000899243-21-024967:0
15 of 15 declarations
About Morrison Scott W
Morrison Scott W is Administrateur and appears in 15 filings in total. In the recent filings we hold, they span 2021-06-21 to 2025-09-16, with 759706 EUR of sales and the most frequent transaction nature shown as Levée d'options. They are associated with Tarsus Pharmaceuticals, Inc., Zai Lab Ltd and Global Blood Therapeutics, Inc.
